Alison Johnson

Company: Boehringer Ingelheim

Job title: Principal Scientist

Seminars:

Utilizing the ELISpot Assay to Quantify T Cell Responses in AAV Gene Therapy 9:30 am

Navigating the complex logistics of the ELISpot assay to ensure viable T cells are analyzed  Discussing the use of the ELISpot assays at different stages of development Preclinical: assessing immunogenicity of AAV vectors Clinical: monitoring for T cell-mediated rejection of AAV gene therapy Optimizing capsid design and selecting capsids to minimize immune response  Addressing potential solutions to…Read more

day: Conference Day One